LAMB2 and neoplasm: Finally, we examined the associations of clinicopathologic factors (sex, age, tumor location, histologic type, p stage, and overall and disease-free survival) with positive/negative expression of laminin and tenascin C. As a result, we observed no statistical differences in the clinicopathologic findings (sex, age, tumor location, histologic type, p stage, overall survival, or disease-free survival) in the patients with positive versus negative expression of laminin (Fig. S2).